Resveratrol and cancer: a review.
The various properties of the stilbene phytoalexin Resveratrol provide interesting new avenues of research in the field of chemoprevention and chemotherapy. A particular emphasis is given on xenobiotic-related carcinogenesis.
Savouret
J F
JF
INSERM unité 135, Hopital de Bicêtre CHU level 3, Le Kremlin-Bicêtre, France. savouret@kb.inserm.fr
Quesne
M
M
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D028502:Polygonum / Q000737:chemistry; D011960:Receptors, Estrogen / Q000378:metabolism; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology* / Q000627:therapeutic use; D015262:Xenobiotics / Q000494:pharmacology
D000972:Antineoplastic Agents, Phytogenic; D004967:Estrogens; D011960:Receptors, Estrogen; D013267:Stilbenes; D015262:Xenobiotics; D000077185:Resveratrol